Old Web
English
Sign In
Acemap
>
authorDetail
>
Ronny W. Renfurm
Ronny W. Renfurm
Center for Global Development
Placebo
Medicine
Anticoagulant
Myocardial infarction
Darexaban
2
Papers
181
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial
2018
The Lancet Diabetes & Endocrinology
Dick de Zeeuw
Ronny W. Renfurm
George L. Bakris
Peter Rossing
Vlado Perkovic
Fan Fan Hou
Masaomi Nangaku
Kumar Sharma
Hiddo J. Lambers-Heerspink
Alberto Garcia-Hernandez
Tobias E Larsson
Show All
Source
Cite
Save
Citations (18)
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
2011
European Heart Journal
Ph. Gabriel Steg
Shamir R. Mehta
J. Wouter Jukema
Gregory Y.H. Lip
C. Michael Gibson
Frantisek Kovar
Petr Kala
Alberto Garcia-Hernandez
Ronny W. Renfurm
Christopher B. Granger
Show All
Source
Cite
Save
Citations (163)
1